DE20221160U1 - Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate - Google Patents
Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate Download PDFInfo
- Publication number
- DE20221160U1 DE20221160U1 DE20221160U DE20221160U DE20221160U1 DE 20221160 U1 DE20221160 U1 DE 20221160U1 DE 20221160 U DE20221160 U DE 20221160U DE 20221160 U DE20221160 U DE 20221160U DE 20221160 U1 DE20221160 U1 DE 20221160U1
- Authority
- DE
- Germany
- Prior art keywords
- fentanyl
- therapeutic system
- transdermal therapeutic
- analgesics
- analogous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
In a transdermal therapeutic system (TTS) comprises a matrix layer based on polyacrylate (I) and containing fentanyl as active agent (A), a backing layer impermeable to (I) and a protective layer to be removed before use, (I) is self-adhesive, is free of carboxy groups and has a saturation solubility for fentanyl of 3-20 wt. % and the (A)-containing layers have at least 80 wt. % of their (A) content in molecular dispersed solution form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE20221160U DE20221160U1 (en) | 2001-08-24 | 2002-07-10 | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10141650A DE10141650C1 (en) | 2001-08-24 | 2001-08-24 | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
EP02762336A EP1418894B1 (en) | 2001-08-24 | 2002-07-10 | Transdermal therapeutic system with fentanyl |
DE20221160U DE20221160U1 (en) | 2001-08-24 | 2002-07-10 | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
Publications (1)
Publication Number | Publication Date |
---|---|
DE20221160U1 true DE20221160U1 (en) | 2005-04-07 |
Family
ID=34105417
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE20221161U Ceased DE20221161U1 (en) | 2001-08-24 | 2002-07-10 | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
DE20221159U Ceased DE20221159U1 (en) | 2001-08-24 | 2002-07-10 | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
DE20221160U Ceased DE20221160U1 (en) | 2001-08-24 | 2002-07-10 | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
DE20221087U Ceased DE20221087U1 (en) | 2001-08-24 | 2002-07-10 | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE20221161U Ceased DE20221161U1 (en) | 2001-08-24 | 2002-07-10 | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
DE20221159U Ceased DE20221159U1 (en) | 2001-08-24 | 2002-07-10 | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE20221087U Ceased DE20221087U1 (en) | 2001-08-24 | 2002-07-10 | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
Country Status (1)
Country | Link |
---|---|
DE (4) | DE20221161U1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10141650C1 (en) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
-
2002
- 2002-07-10 DE DE20221161U patent/DE20221161U1/en not_active Ceased
- 2002-07-10 DE DE20221159U patent/DE20221159U1/en not_active Ceased
- 2002-07-10 DE DE20221160U patent/DE20221160U1/en not_active Ceased
- 2002-07-10 DE DE20221087U patent/DE20221087U1/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DE20221161U1 (en) | 2005-04-07 |
DE20221087U1 (en) | 2005-01-20 |
DE20221159U1 (en) | 2005-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50209364D1 (en) | Transdermales therapeutisches system mit fentanyl | |
AU7253501A (en) | Transdermal therapeutic system for highly dispersed silicon dioxide | |
NO20050472L (en) | Improved transdermal delivery system for the administration of rotigotine | |
TW570815B (en) | Transdermal therapeutic system (TTS) containing the active substance fentanyl | |
IL108235A0 (en) | Transdermal therapeutic system containing galanthamine | |
HK1083458A1 (en) | Improved transdermal delivery system | |
CO5640120A2 (en) | FORMULATION AND METHODS FOR THE TROMBOCITEMIA TREATMENT | |
WO2001068060A3 (en) | Stabilised oversaturated transdermal therapeutical matrix systems | |
AU2108300A (en) | Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids | |
HU900199D0 (en) | Process for production of surface therapic system comprising 5-fluoruracil as active ingredient | |
AU1013202A (en) | Occlusive transdermal therapeutic system with a non-occlusive backing layer | |
DE20221159U1 (en) | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate | |
AU2001230193A1 (en) | Transdermal therapeutic system for the administration of zaleplon | |
DE20221247U1 (en) | Transdermal patch, useful for administering fentanyl or its analog through the skin, comprises a backing layer on which a reservoir containing a single phase polymeric composition is disposed | |
YU71293A (en) | TRANSDERMAL THERAPY SYSTEM FOR THE PROMOTION OF PHYSOSTIGMIN ON THE SKIN AND THE PROCEDURE FOR ITS MAKING |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R207 | Utility model specification |
Effective date: 20050512 |
|
R165 | Request for cancellation or ruling filed | ||
R150 | Utility model maintained after payment of first maintenance fee after three years |
Effective date: 20050729 |
|
R165 | Request for cancellation or ruling filed | ||
R151 | Utility model maintained after payment of second maintenance fee after six years |
Effective date: 20081007 |
|
R168 | Utility model cancelled |
Effective date: 20070905 |